ClassID:

20308

A61K31/396 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having three-membered rings, e.g. aziridine

Recent Application in this class:
#1
20260137650
2026-05-21

MODULATORS OF RAR RELATED ORPHAN RECEPTORS (RORs)

#2
20250230125
2025-07-17

Small Molecule Allosteric Modulators of Serotonin (5-HT) 5-HT2C and 5-HT2A Receptors

#3
20250206708
2025-06-26

AN OXAZIRIDINE PLATFORM FOR TARGETING FUNCTIONAL ALLOSTERIC METHIONINE SITES

#4
20250171456
2025-05-29

PSYCHEDELIC COMPOUNDS AND THEIR THERAPEUTIC USES

#5
20240336559
2024-10-10

ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS

#6
20240294465
2024-09-05

NOVEL ANTI-FIBROTIC DRUGS

#7
20220387395
2022-12-08

UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION

#8
20220387345
2022-12-08

ANTI-CANCER COMPOUNDS ACTING AS NON-PGP SUBSTRATE

#9
20220362269
2022-11-17

METHOD FOR TREATMENT OF PANCREATITIS

#10
20220339129
2022-10-27

Bicyclic amide compounds and methods of use thereof

#11
20220226474
2022-07-21

ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND COMPOSITIONS FOR THE TREATMENT OF CANCER

#12
20220031669
2022-02-03

Compositions for Broad Spectrum Topical Antimicrobials

#13
20210393583
2021-12-23

Method for the treatment of pancreatitis

#14
20210299070
2021-09-30

METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY

#15
20210228594
2021-07-29

METHODS FOR TREATING CARDIAC VALVE DISEASE

#16
20210198239
2021-07-01

COMPOUNDS AND METHODS FOR CD73 MODULATION AND INDICATIONS THEREFOR

#17
20210040478
2021-02-11

Method of fixing and expressing physiologically active substance

#18
20200093928
2020-03-26

Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancer

#19
20200085786
2020-03-19

Aziridine containing DNA alkylating agents

#20
20200078476
2020-03-12

Aryl ethene derivative and pharmaceutical composition containing same as active ingredient

#21
20200046714
2020-02-13

Treating male senescence

#22
20200030246
2020-01-30

Composition for hepatic arterial chemoembolization using human serum albumin nanoparticles carrying anticancer agent, and method for producing same

#23
20190225633
2019-07-25

DNA alkylating agents

#24
20190167820
2019-06-06

NOVEL ARYL ETHENE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT

#25
20190161490
2019-05-30

Aryl ethene derivative and pharmaceutical composition containing same as active ingredient

#26
20190153447
2019-05-23

Method of fixing and expressing physiologically active substance

#27
20180344691
2018-12-06

Substituted phenyl aziridine precursor analogs for inhibiting androgen-independent prostate cancer cell growth

#28
20180170878
2018-06-21

Photocrosslinking reagents and methods of use thereof

#29
20180169064
2018-06-21

AZIRIDINE CONTAINING DNA ALKYLATING AGENTS

#30
20180153831
2018-06-07

Bicyclic amide compounds and methods of use thereof

#31
20180140575
2018-05-24

Use of alpha-hydroxy carbonyl compounds as reducing agents

#32
20180044360
2018-02-15

DNA alkylating agents

#33
20170216249
2017-08-03

Substituted Phenyl Aziridine Precursor Analogs for Inhibiting Androgen-Independent Prostate Cancer Cell Growth

#34
20160287675
2016-10-06

Treatment for cancer

#35
20160272603
2016-09-22

Trail enhancers for the selective killing of cancer cells

#36
20160194307
2016-07-07

Compounds useful as immunomodulators

#37
20160089354
2016-03-31

Substituted Phenyl Aziridine Precursor Analogs for Inhibiting Androgen-Independent Cancer Cell Growth

#38
20160058734
2016-03-03

Heteroarylcarboxylic acid ester derivative

#39
20150231113
2015-08-20

Use of alpha-hydroxy carbonyl compounds as reducing agents

#40
20150210639
2015-07-30

Quinone compounds and their uses for the treatment of cancer

#41
20140336174
2014-11-13

Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease

#42
20140148398
2014-05-29

Methods of treating giardiasis

#43
20140105824
2014-04-17

Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods

#44
20130338132
2013-12-19

Heteroarylcarboxylic acid ester derivative

#45
20130336962
2013-12-19

Aziridine bisphenol ethers and related compounds and methods for their use

#46
20120164065
2012-06-28

METHOD AND COMPOSITION FOR TREATING CANCER

#47
20110281844
2011-11-17

NON-IMIDAZOLE ALKYLAMINES AS HISTAMINE H3-RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS

#48
20110166134
2011-07-07

Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease

#49
20110158948
2011-06-30

Treatment Using Herpes Simplex Virus

#50
20100329993
2010-12-30

METHOD OF FIXING AND EXPRESSING PHYSIOLOGICALLY ACTIVE SUBSTANCE

#51
20100273762
2010-10-28

Method of combating infection

#52
20100190705
2010-07-29

Suppression of glial fibrillary acidic protein

#53
20100104515
2010-04-29

Use of alpha-hydroxy carbonyl compounds as reducing agents

#54
20090311188
2009-12-17

In vivo methods of identifying compounds which target suppressed cancer cells

#55
20090221581
2009-09-03

Methods of treating pain

#56
20090163570
2009-06-25

BLADDER CANCER TREATMENT AND METHODS

#57
20090156672
2009-06-18

Substituted Phenyl Aziridine Precursor Analogs as Modulators of Steroid Receptor Activities

#58
20090010889
2009-01-08

Treatment using herpes simplex virus

#59
20080279764
2008-11-13

METHOD AND COMPOSITION FOR TREATING CANCER

#60
20070254862
2007-11-01

Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators

#61
20070203112
2007-08-30

BLADDER CANCER TREATMENT AND METHODS

#62
20070203109
2007-08-30

Compounds And Compositions For Treatment Of Cancer

#63
20070185188
2007-08-09

BLADDER CANCER TREATMENT AND METHODS

#64
20070123483
2007-05-31

Method and composition for treating obesity by targeting cathespin

#65
20060247223
2006-11-02

Non-imidazole alkylamines as histamine H- receptor ligands and their therapeutic applications

#66
20060216297
2006-09-28

Method and composition for reducing blood sugar levels or fat storage by targeting cathepsin

#67
20060128611
2006-06-15

Composition for enzyme inhibition

#68
20050074743
2005-04-07

Method and composition for treating a biological sample